Golidocitinib 1-hydroxy-2-naphthoate
Product Specifications
CAS Number
2091134-68-6 (free base)
Target
JAK
Applications
Angiogenesis
Additionnal Information
Golidocitinib 1-hydroxy-2-naphthoate is a derivative of Golidocitinib, an oral, potent, selective inhibitor of Janus kinase 1 (JAK1) with an IC50 of 70 nM. It exhibits enhnaced antitumor activity and can be used for the treatment of cancer, including peripheral T cell lymphoma (PTCL) .
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1195439-01 0.02 mg (E-Coli)
Recombinant Haemophilus influenzae Molybdate-binding periplasmic protein (modA)
Sign In for Pricing
View Details MBS1195439-02 0.1 mg (E-Coli)
Recombinant Haemophilus influenzae Molybdate-binding periplasmic protein (modA)
Sign In for Pricing
View Details MBS1195439-03 0.02 mg (Yeast)
Recombinant Haemophilus influenzae Molybdate-binding periplasmic protein (modA)
Sign In for Pricing
View Details MBS1195439-04 0.1 mg (Yeast)
Recombinant Haemophilus influenzae Molybdate-binding periplasmic protein (modA)
Sign In for Pricing
View Details MBS1195439-05 0.02 mg (Baculovirus)
Recombinant Haemophilus influenzae Molybdate-binding periplasmic protein (modA)
Sign In for Pricing
View Details MBS1195439-06 0.02 mg (Mammalian-Cell)
Recombinant Haemophilus influenzae Molybdate-binding periplasmic protein (modA)
Sign In for Pricing
View Details